Position in NBIX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$9,989,027
+$3,891,048 QoQ
Shares Held
59,268
+28.0% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#158
of 772 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 87%
Shared 0%
None 13%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Boston Partners holds $66,889,026 across 3 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (14.9% of the industry book) .
All Filings in NBIX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,989,027 | 59,268 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $6,097,979 | 46,288 | Shares | Other | 2026-05-11 | |
| 2025-12-31 | $7,725,762 | 54,472 | Shares | Other | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||